Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | August 18, 2020 | August 20, 2020 |
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | Director | May 01, 2026 | May 04, 2026 |
| PEPSICO INCPEP · Entity 2848 | Vice Chair,EVP,CSO,Global R&D | March 01, 2019 | March 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date August 18, 2020 · Filed August 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 178,767 |
Ending reported balance
After 2020-08-19 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-08-18 · Purchase · Acquired 2,331 · Balance 135,348 Row 2 · 2020-08-18 · Purchase · Acquired 4,500 · Balance 139,848 Row 3 · 2020-08-18 · Purchase · Acquired 21,082 · Balance 160,930 Row 4 · 2020-08-19 · Purchase · Acquired 9,404 · Balance 170,334 Row 5 · 2020-08-19 · Purchase · Acquired 8,433 · Balance 178,767 |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $5.63 · Expires 2030-02-25 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2020-08-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 15,000 F1: These options were granted on 02/25/2020. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $8.30 · Expires 2029-01-10 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2020-08-18 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 15,000 F2: These options were granted on 01/10/2019. These options are fully vested. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $2.85 · Expires 2028-02-16 | Direct | 8,000 |
Reported balance
Holding disclosure · report date 2020-08-18 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 8,000 F3: These options were granted on 02/16/2018. These options are fully vested. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2027-06-25 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2020-08-18 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 15,000 F4: These options were granted on 06/25/2017. These options are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on 02/25/2020. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F2: These options were granted on 01/10/2019. These options are fully vested.
F3: These options were granted on 02/16/2018. These options are fully vested.
F4: These options were granted on 06/25/2017. These options are fully vested.
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,173 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Exercise / conversion · Acquired 2,569 · Balance 7,173 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-05-01 | Direct | 0 |
Reported balance
After 2026-05-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-01 · Exercise / conversion · Disposed 2,569 · Balance 0 F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2: Represent RSUs granted under the Non-Employee Director Compensation Program. F3: On May 1, 2025, the reporting person was granted 2,569 restricted stock units, all of which vested on May 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.
F2: Represent RSUs granted under the Non-Employee Director Compensation Program.
F3: On May 1, 2025, the reporting person was granted 2,569 restricted stock units, all of which vested on May 1, 2026.
PEPSICO INC
Report date March 01, 2019 · Filed March 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| PepsiCo, Inc. Common StockSEC Table I · non-derivative | Direct | 74,712.06 |
Ending reported balance
After 2019-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-03-01 · Grant · Acquired 13,534 · Balance 89,529.06 F1: This number represents the shares of PepsiCo Common Stock acquired upon vesting of additional performance-based restricted stock units ("PSUs") granted in March 2016, as a result of exceeding pre-established performance targets. Row 2 · 2019-03-01 · Tax withholding · Disposed 14,817 · Balance 74,712.06 F2: This number represents shares of PepsiCo Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs. |
| PepsiCo, Inc. Common StockSEC Table I · non-derivative | Indirect401(k) | 227.7152 |
Reported balance
Holding disclosure · report date 2019-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 227.7152 F3: Reflects the number of shares held under the reporting person's account in the PepsiCo Savings Plan as of March 1, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents the shares of PepsiCo Common Stock acquired upon vesting of additional performance-based restricted stock units ("PSUs") granted in March 2016, as a result of exceeding pre-established performance targets.
F2: This number represents shares of PepsiCo Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs.
F3: Reflects the number of shares held under the reporting person's account in the PepsiCo Savings Plan as of March 1, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 4, 2026 21:22 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 2,569 | $70.81 | $181,910.89 |
DisclosureSEC source: 0001225208-26-004892 · doc4.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,569 shares Expires 2026-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F3 · derivative.exercise_date: On May 1, 2025, the reporting person was granted 2,569 restricted stock units, all of which vested on May 1, 2026. F3 · derivative.expiration_date: On May 1, 2025, the reporting person was granted 2,569 restricted stock units, all of which vested on May 1, 2026. Read SEC document |
| May 01, 2026 Filed May 4, 2026 21:22 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 2,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004892 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| April 29, 2026 Filed Apr 30, 2026 20:50 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 2,903 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-004741 · doc4.xml · derivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,903 Underlying: Common Stock · 2,903 shares Expires 2027-04-29 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The RSUs will vest on the one-year anniversary of the grant date. F3 · derivative.expiration_date: The RSUs will vest on the one-year anniversary of the grant date. Read SEC document |
| May 15, 2025 Filed May 15, 2025 21:27 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | PurchaseCommon Stock | 300 | $75.32 | $22,596.00 |
DisclosureSEC source: 0001225208-25-005177 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,604 Read SEC document |
| May 15, 2025 Filed May 15, 2025 21:27 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | PurchaseCommon Stock | 3,700 | $75.33 | $278,717.67 |
DisclosureSEC source: 0001225208-25-005177 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,304 Read SEC document |
| May 01, 2025 Filed May 5, 2025 21:47 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 2,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004744 · doc4.xml · derivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,569 Underlying: Common Stock · 2,569 shares Expires 2026-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F3 · shares: Represent RSUs granted under the Non-Employee Director Compensation Program. F4 · derivative.exercise_date: The RSUs will vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: The RSUs will vest on the one-year anniversary of the grant date. Read SEC document |
| May 01, 2025 Filed May 5, 2025 21:47 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 604 | $77.85 | $47,021.40 |
DisclosureSEC source: 0001225208-25-004744 · doc4.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 604 shares Expires 2025-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. F2 · derivative.exercise_date: On February 3, 2025, the reporting person was granted 604 RSUs, all of which vested on May 1, 2025. F2 · derivative.expiration_date: On February 3, 2025, the reporting person was granted 604 RSUs, all of which vested on May 1, 2025. Read SEC document |
| May 01, 2025 Filed May 5, 2025 21:47 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-004744 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001284 · doc4.xml · derivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604 Underlying: Common Stock · 604 shares Expires 2025-05-01 F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 8,433 | $4.90 | $41,295.56 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 5 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,767 Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 9,404 | $4.91 | $46,176.46 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,334 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 21,082 | $4.86 | $102,365.76 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,930 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 4,500 | $4.62 | $20,790.00 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,848 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 2,331 | $4.60 | $10,722.60 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,348 Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:47 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004980 · doc4.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: These options were granted on 02/25/2020. These options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:09 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 17,000 | $6.58 | $111,924.60 |
DisclosureSEC source: 0001213900-19-026361 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,017 F1 · price: Reflects the weighted average price of purchases made on the NYSE American on December 13, 2019. The shares were purchased in multiple transactions at prices ranging from $6.47 to $6.75, inclusive. The reporting person undertakes to provide to CorMedix Inc., any security holder of CorMedix Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:50 UTC | PEPSICO INC PEP · Entity 2848 | Tax withholdingPepsiCo, Inc. Common Stock | 14,817 | $115.80 | $1,715,808.60 |
DisclosureSEC source: 0001209191-19-016634 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,712.06 F2 · shares: This number represents shares of PepsiCo Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:50 UTC | PEPSICO INC PEP · Entity 2848 | GrantPepsiCo, Inc. Common Stock | 13,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016634 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,529.06 F1 · shares: This number represents the shares of PepsiCo Common Stock acquired upon vesting of additional performance-based restricted stock units ("PSUs") granted in March 2016, as a result of exceeding pre-established performance targets. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001654954-19-000382 · section16.xml · derivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-10 F2 · derivative.exercise_date: These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000382 · section16.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,083 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 10, 2019 Filed Jan 11, 2019 21:16 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-000382 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,083 F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 21:16 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 100,000 | $1.24 | $124,410.00 |
DisclosureSEC source: 0001654954-18-014238 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,583 Read SEC document |
| October 23, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 57,305 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · derivative · entry 11 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: PepsiCo, Inc. Common Stock · 57,305 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | SalePepsiCo, Inc. Common Stock | 40,075 | $110.13 | $4,413,539.90 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 7 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,995.06 F4 · price: The shares with respect to this transaction were sold at prices ranging from $110.00 and $110.24, a portion of which were sold to cover taxes and broker commissions. Upon request, the reporting person will provide to the Securities and Exchange Commission staff, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 23, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | SalePepsiCo, Inc. Common Stock | 57,305 | $110.05 | $6,306,604.36 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 6 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,070.06 F3 · price: The shares with respect to this transaction were sold at prices ranging from $110.00 and $110.12, a portion of which were sold to cover option costs, taxes and broker commissions. Upon request, the reporting person will provide to the Securities and Exchange Commission staff, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 23, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionPepsiCo, Inc. Common Stock | 57,305 | $63.75 | $3,653,193.75 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 5 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,375.06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,283 | $0.00 Strike: $63.75 | $0.00 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · derivative · entry 10 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,305 Underlying: PepsiCo, Inc. Common Stock · 13,283 shares Expires 2021-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,526 | $0.00 Strike: $66.50 | $0.00 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · derivative · entry 9 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: PepsiCo, Inc. Common Stock · 50,526 shares Expires 2020-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | SalePepsiCo, Inc. Common Stock | 7,106 | $110.46 | $784,952.21 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 4 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,070.06 F2 · price: The shares with respect to this transaction were sold at prices ranging from $110.40 and $110.61, a portion of which were sold to cover taxes and broker commissions. Upon request, the reporting person will provide to the Securities and Exchange Commission staff, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | SalePepsiCo, Inc. Common Stock | 63,809 | $110.13 | $7,027,591.45 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,176.06 F1 · price: The shares with respect to this transaction were sold at prices ranging from $110.00 and $110.85, a portion of which were sold to cover option costs, taxes and broker commissions. Upon request, the reporting person will provide to the Securities and Exchange Commission staff, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionPepsiCo, Inc. Common Stock | 13,283 | $63.75 | $846,791.25 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,985.06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:55 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionPepsiCo, Inc. Common Stock | 50,526 | $66.50 | $3,359,979.00 |
DisclosureSEC source: 0001209191-18-056068 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,702.06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:51 UTC | PEPSICO INC PEP · Entity 2848 | Tax withholdingPepsiCo, Inc. Common Stock | 8,979 | $108.12 | $970,809.48 |
DisclosureSEC source: 0001209191-18-016751 · doc4.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,176.06 F3 · shares: This number represents shares of PepsiCo Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PEPunits. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:51 UTC | PEPSICO INC PEP · Entity 2848 | GrantPepsiCo, Inc. Common Stock | 2,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016751 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,155.06 F2 · shares: This number represents the shares of PepsiCo Common Stock acquired upon vesting of additional PepsiCo Equity Performance Units ("PEPunits") granted in March 2015, as a result of exceeding pre-established performance targets. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:51 UTC | PEPSICO INC PEP · Entity 2848 | GrantPepsiCo, Inc. Common Stock | 18,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-016751 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,843.06 F1 · shares: This number represents the performance-based restricted stock units ("PSUs") granted as a portion of the reporting person's compensation from PepsiCo, Inc. These PSUs will become vested on March 1, 2021 contingent upon the achievement of pre-established performance targets over a three-year performance period and Compensation Committee approval. The reporting person may receive a number of shares of PepsiCo Common Stock from 0% to 175% of the PSUs granted, depending on the performance level achieved. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001720 · section16.xml · derivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 21:17 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013413 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,583 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with vesting in full on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:11 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011652 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,083 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 20:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $0.42 | $21,000.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 5 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Read SEC document |
| August 17, 2017 Filed Aug 22, 2017 20:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 150,000 | $0.41 | $61,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Read SEC document |
| August 16, 2017 Filed Aug 22, 2017 20:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 100,000 | $0.39 | $39,000.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| August 15, 2017 Filed Aug 22, 2017 20:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $0.37 | $18,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| August 14, 2017 Filed Aug 22, 2017 20:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 50,000 | $0.35 | $17,500.00 |
DisclosureSEC source: 0001654954-17-007835 · section16.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 23:33 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 63,396 | $0.00 Strike: $53.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046370 · doc4.xml · derivative · entry 4 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: PepsiCo, Inc. Common Stock · 63,396 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 23:33 UTC | PEPSICO INC PEP · Entity 2848 | SalePepsiCo, Inc. Common Stock | 63,396 | $116.39 | $7,378,368.82 |
DisclosureSEC source: 0001209191-17-046370 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,877.06 F1 · price: The shares with respect to this transaction were sold at prices ranging from $116.11 and $116.63, a portion of which were sold to cover option costs, taxes and broker commissions. Upon request, the reporting person will provide to the Securities and Exchange Commission staff, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 23:33 UTC | PEPSICO INC PEP · Entity 2848 | Exercise / conversionPepsiCo, Inc. Common Stock | 63,396 | $53.00 | $3,359,988.00 |
DisclosureSEC source: 0001209191-17-046370 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,273.06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2017 Filed Jun 27, 2017 20:04 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 75,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001654954-17-005931 · section16.xml · derivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-06-25 F1 · derivative.exercise_date: These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:30 UTC | PEPSICO INC PEP · Entity 2848 | Tax withholdingPepsiCo, Inc. Common Stock | 11,441 | $109.75 | $1,255,592.55 |
DisclosureSEC source: 0001209191-17-017790 · doc4.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Vice Chair,EVP,CSO,Global R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,877.06 F3 · shares: This number represents shares of PepsiCo Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PEPunits. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.